Regencell Bioscience (RGC) has had the highest return between March 1, 2024 and December 9, 2025 by a mid-cap US stock, returning 8,776.1%.
Regencell Bioscience (RGC) has had the highest return between March 1, 2024 and December 9, 2025 by a mid-cap US stock, returning 8,776.1%.
Mid-cap stocks are treated as having a market cap between $2B and $10B.